Clinical Trials
🇺🇸 FDA Page 5FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 49–60 of 380 articles
Daraxonrasib Doubles Survival in Pancreatic Cancer: What Pharma Teams Need to Know
OHRP Underfunding Risks Human Subject Protection in 2026
ADC Specialist Sinks on Safety Concerns: What Pharma Teams Need to Know
FDA Voucher Program Under Fire: Pharma and Patient Groups Demand Pause
STAT+: RFK Jr.’s second year: Vacancies, not vaccines
HHS Confirms Americans with High-Risk Ebola Exposures Will Have Access to Experimental Therapy MBP-134
FDA Extends Comment Period for Real-Time Clinical Trials Pilot, AI Use in Studies
Kairos Pharma Highlights CL-741 Acquisition and 2026 Clinical Milestones: A Strategic Analysis for Pharma Decision-Makers
Daraxonrasib Pancreatic Cancer: What RevMed’s Breakthrough Means for Patients and Pharma
AI Titans Push Congress for DNA Safeguards: Implications for Biotech Strategy
Revolution Medicine Pancreatic Cancer: Demand Surge Strains Daraxonrasib Access
Opinion: Lawmakers promised cancer patients would be protected from Medicaid cuts. Now CMS says otherwise